Vaxart Stock

Vaxart FCF Yield

The Free Cash Flow Yield of Vaxart (VXRT) as of Aug 12, 2026 is 4.98 %. In the previous year, Free Cash Flow Yield was -29.85 % — a change of -116.70% (higher).

FCF Yield

4.98 %

YoY

-116.70%

Last updated:

Free Cash Flow Yield of Vaxart is 2026 4.98 % . Free Cash Flow Yield of Vaxart was 2025 -29.85 % . It decreases by -116.70% higher compared to the previous year.
Access this data via the Eulerpool API

Vaxart Stock analysis

What does Vaxart do? Vaxart Inc is a US biotechnology company that was founded in 2004 and is based in South San Francisco, California. The company specializes in the development of oral vaccines and therapeutics. Vaxart is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vaxart stock

Free Cash Flow Yield of Vaxart is 4.98 % in 2026.

Free Cash Flow Yield of Vaxart changed from -29.85 % to 4.98 %, representing a -116.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Vaxart since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Vaxart with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vaxart

All Key Metrics — Vaxart